CHEK2 and breast cancer: Previously, we have identified pathogenic mutations of BRCA1, BRCA2, CHEK2, and PALB2 in about half of 1018 Polish families with hereditary breast cancer, and we have observed that 18 founder mutations are responsible for about 80% of all the mutations detected in these genes [45].